Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

A TI-RADS 5 thyroid nodule with repeat Bethesda III cytology and final diagnosis of classic papillary thyroid carcinoma: A case report

Breadcrumb

  • Home
  • A TI-RADS 5 thyroid nodule with repeat Bethesda III cytology and final diagnosis of classic papillary thyroid carcinoma: A case report

Huynh Thi Do Quyen 1, *, Nguyen Vu Quynh Anh 1, Pham Hieu 2 and Tran Minh Tuan 3

1 Department of Endoscopic Ultrasound, Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, Vietnam.
2 Department of Pathology, Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, Vietnam.
3 Department of General Oncology, Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, Vietnam.

Case Report

World Journal of Biology Pharmacy and Health Sciences, 2026, 26(01), 152-156

Article DOI: 10.30574/wjbphs.2026.26.1.0207

DOI url: https://doi.org/10.30574/wjbphs.2026.26.1.0207

Received on 09 March 2026; revised on 18 April 2026; accepted on 20 April 2026

Background: Bethesda category III thyroid nodules remain a diagnostic challenge because the risk of malignancy is intermediate and management should not rely on cytology alone. Ultrasound risk stratification is particularly important when cytological findings are discordant or persistently indeterminate.
Case presentation: We report the case of a 50-year-old woman presenting with swallowing discomfort. Thyroid ultrasound demonstrated a highly suspicious right thyroid nodule classified as ACR TI-RADS 5, together with a suspicious right level IV cervical lymph node. Initial fine-needle aspiration (FNA) of the thyroid nodule showed nodular hyperplasia, whereas repeat FNA after follow-up yielded Bethesda III cytology. Because of the persistently high-risk ultrasound appearance, the patient underwent total thyroidectomy with central neck dissection. Histopathology confirmed classic papillary thyroid carcinoma, while the dissected lymph nodes were inflammatory.
Conclusion: This case highlights the importance of integrating ultrasound findings, repeat cytology, and clinical judgment in the management of Bethesda III thyroid nodules. A benign or indeterminate FNA result does not exclude malignancy when sonographic features are strongly suspicious.

Bethesda III; Atypia of Undetermined Significance; Thyroid Nodule; TI-RADS 5; Papillary Thyroid Carcinoma

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2026-0207.pdf

Get Your e Certificate of Publication using below link

Download Certificate

Preview Article PDF

Huynh Thi Do Quyen, Nguyen Vu Quynh Anh, Pham Hieu and Tran Minh Tuan. A TI-RADS 5 thyroid nodule with repeat Bethesda III cytology and final diagnosis of classic papillary thyroid carcinoma: A case report. World Journal of Biology Pharmacy and Health Sciences, 2026, 26(01), 152-156. Article DOI: https://doi.org/10.30574/wjbphs.2026.26.1.0207
 

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution